Vertex resumes trial after patient deaths
Following a three month pause in early 2024, Vertex is resuming the trial of VX-880, an investigational stem cell therapy used to restore insulin production
Following a three month pause in early 2024, Vertex is resuming the trial of VX-880, an investigational stem cell therapy used to restore insulin production
Britain’s decision to further delay rules banning multi-buy deals on food and drinks high in fat, salt, or sugar (HFSS) has dismayed health campaigners who
The lecture, organised by the Sheffield branch of Diabetes UK, on Thursday 18 July from 7pm to 9pm. You can attend in person (at 11
High levels of xylitol, a low-calorie sweetener used in many reduced-sugar foods, as well as gum and toothpaste, are linked to an increased risk of
New research has found that adult patients with poorly controlled Type 1 diabetes on insulin pumps and continuous glucose monitoring (CGM) systems could benefit from
Medicare will start covering Senseonics’ implantable continuous glucose monitor (CGM) for a broader group of patients from late February. Last year, Medicare updated its policy
Dealing with Type 1 every day can have an emotional impact. Constant blood glucose tests and targets can lead to stress, and the relentlessness of
Recent research has found that metformin use lowers the risk of gout by 32% in individuals with prediabetes. Individuals with prediabetes are not only at
A new study by INSEAD has shown that exposure to natural scenery can nudge people to pick healthier food. Published in Communications Psychology, a new
Our front cover this issue is the first (and probably the last) time that I’ve actually used a product shot, as the little girl jumping